(Q37544822)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19586421%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

review article

1 reference

title

Pharmacotherapy of endometrial cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19586421%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19586421%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

4

Jason D Wright

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19586421%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

author name string

Nicanor I Barrena Medel

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19586421%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Sharmilee Bansal

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19586421%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Thomas J Herzog

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19586421%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

language of work or name

English

0 references

publication date

1 August 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19586421%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Pharmacotherapy

2 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19586421%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19586421%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19586421%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

page(s)

1939-1951

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19586421%20AND%20SRC:MED&resulttype=core&format=json

Two pathogenetic types of endometrial carcinoma

2 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656560903061291

Thin endometrial echo complex on ultrasound does not reliably exclude type 2 endometrial cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903061291

Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903061291

New aspects of adjuvant therapy in endometrial cancer: current standards and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903061291

High-risk endometrial cancer subgroups: candidates for target-based adjuvant therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903061291

Hematogenous dissemination in corpus cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903061291

Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903061291

Adjuvant radiotherapy in women with stage I endometrial cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903061291

Adjuvant radiotherapy for stage I endometrial cancer: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903061291

Survival and recurrent disease after postoperative radiotherapy for early endometrial cancer: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903061291

Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903061291

Adjuvant chemotherapy as treatment of high-risk stage I and II endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903061291

Efficacy and prognostic implications of administering adjuvant chemotherapy to patients with endometrial cancer that is confined to the uterus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903061291

Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903061291

Significance of comprehensive surgical staging in noninvasive papillary serous carcinoma of the endometrium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903061291

Minimal uterine serous carcinoma: diagnosis and clinicopathologic correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903061291

Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903061291

Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903061291

Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903061291

The relationship between histology and outcome in advanced and recurrent endometrial cancer patients participating in first-line chemotherapy trials: a Gynecologic Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903061291

Systemic therapy in metastatic or recurrent endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903061291

Systematic review of systemic therapy for advanced or recurrent endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903061291

Chemotherapy for advanced, recurrent or metastatic endometrial cancer: a systematic review of Cochrane collaboration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903061291

Carboplatin and paclitaxel in advanced or metastatic endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903061291

Sparing fertility in young patients with endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903061291

Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903061291

Megestrol and tamoxifen in patients with advanced endometrial cancer: an Eastern Cooperative Oncology Group Study (E4882).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903061291

Hormone therapy in advanced and recurrent endometrial cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903061291

The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903061291

Surgically staged high-risk endometrial cancer: randomized study of adjuvant radiotherapy alone vs. sequential chemo-radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903061291

Molecule-targeted agents in endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903061291

Novel therapeutic strategy for uterine endometrial cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903061291

Molecular target therapies in endometrial cancer: from the basic research to the clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903061291

A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903061291

Radiologic staging in patients with endometrial cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903061291

A systematic review of tests for lymph node status in primary endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903061291

A need for laparoscopic evaluation of patients with endometrial carcinoma selected for conservative treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903061291

Randomized Phase III Trial of Whole-Abdominal Irradiation Versus Doxorubicin and Cisplatin Chemotherapy in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903061291

10.1517/14656560903061291

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19586421%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference